APR 13, 2020 6:35 AM PDT

Are COVID-19 Antibody Tests a Back-to-Work Pass?

WRITTEN BY: Annie Lennon

Although treatments and vaccines against COVID-19 may still be months away, antibody tests are becoming more widespread. Already, over 70 developers have contacted the FDA to let them know that they have such tests available. Does this mean that they may be used as a pass to allow people to go back to work? 

On April 10th, the National Institutes of Health announced that it would test 10,000 healthy people around the US for the presence of antibodies in their blood. Dr Anthong S. Fauci, a lead member of the Trump Administration’s White House Coronavirus Task Force said, “As we get to the point of considering opening the country...it is very important to understand how much that virus has penetrated society.”

Depending on the success of the antibody tests, he also mentioned the idea of issuing a ‘certificate of immunity’ to people who were previously infected. But would these certificates really be enough to allow people to go back to work? 

Antibody tests work by detecting antibodies in the blood specific to a certain disease. If these antibodies appear in a person’s blood, it’s likely that they already developed an immune response to a certain pathogen. Not only has this person likely already had the disease, but they likely will be able to use the same antibodies again to defend against it. 

Although antibody tests could theoretically be used to allow citizens back to work, there are some issues around their functionality. To begin, some people who may have already had the virus and had mild or no symptoms may have not developed sufficient antibodies to prevent re-infection. Moreover, people who test positive for antibodies may still be infectious. 

Antibody tests already used in the UK have been plagued by false results. False positives may be particularly dangerous as they may falsely claim someone to be immune from the virus when in fact, they are at risk. 

Thus, before COVID-19 antibody tests may be properly considered as a route for people to return to work, further research is needed to confirm their efficacy. Until then, working from home and social distancing are still recommended, regardless of whether or not you think you have had the virus. 


Sources: NIH, NYTimes, Japan Times

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
MAR 21, 2021
Microbiology
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
MAR 21, 2021
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
A mouse model has shown that it's possible to clear a multi-drug resistant gonorrhea with only one dose of antibioti ...
MAR 09, 2021
Drug Discovery & Development
Leprosy Drug Repurposed for Potential COVID19 Treatment
MAR 09, 2021
Leprosy Drug Repurposed for Potential COVID19 Treatment
New research published in Nature study shows that a drug for treating leprosy was repurposed to treat COVID19. The study ...
APR 01, 2021
Microbiology
Mapping the Wild Microbiome to Search for Therapeutic Agents
APR 01, 2021
Mapping the Wild Microbiome to Search for Therapeutic Agents
Many people think of bacteria as disgusting germs, but there are plenty of important bacterial species that provide us w ...
APR 17, 2021
Drug Discovery & Development
Nanofiber-Based Drug Treats Inflammation
APR 17, 2021
Nanofiber-Based Drug Treats Inflammation
Researchers at Duke University worked on creating a self-assembling nanomaterial-based drug that can help address damage ...
MAY 03, 2021
Drug Discovery & Development
Low Dose Radiation May Improve Symptoms of Alzheimer's
MAY 03, 2021
Low Dose Radiation May Improve Symptoms of Alzheimer's
While high doses of radiation are known to be harmful, low doses may be able to help the body protect and repair. And no ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
Loading Comments...